Tema ETFs’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Tema ETFs's BMY Position: Q2 2026 in Review
Tema ETFs increased its Bristol-Myers Squibb (BMY) stake by 6.4% in Q2 2026, buying an estimated $570K and bringing the position to 164,530 shares worth $9.48M. The position accounts for 0.31% of the portfolio, ranked #75.
Tema ETFs first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. 814 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Tema ETFs held 164,530 shares of Bristol-Myers Squibb worth $9.48M as of Q2 2026.
- Tema ETFs bought 9,933 Bristol-Myers Squibb shares in Q2 2026, an estimated $570K.
- Bristol-Myers Squibb made up 0.31% of Tema ETFs's portfolio in Q2 2026, its #75 holding.
- Tema ETFs first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
- 814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.